A SINGLE AMINO-ACID CHANGE IN A MYELIN BASIC-PROTEIN PEPTIDE CONFERS THE CAPACITY TO PREVENT RATHER THAN INDUCE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
A SINGLE AMINO-ACID CHANGE IN A MYELIN BASIC-PROTEIN PEPTIDE CONFERS THE CAPACITY TO PREVENT RATHER THAN INDUCE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
复制标题
DOI:
10.1073/pnas.88.21.9633
复制
发表时间:
1991-11-01
影响因子:
11.1
通讯作者:
MCDEVITT, HO
中科院分区:
文献类型:
--
作者:
SMILEK, DE;WRAITH, DC;MCDEVITT, HO
Experimental autoimmune encephalomyelitis (EAE) is an experimental demyelinating disease of rodents. In (PL/J x SJL)F1 mice, it is induced by immunization with the myelin basic protein peptide Ac1-11. Ac1-11[4A], a myelin basic protein peptide analog with a single amino acid substitution, (i) binds to class II major histocompatibility complex molecules and stimulates encephalitogenic T cells in vitro better than Ac1-11, (ii) is nonimmunogenic and nonencephalitogenic in vivo in (PL/J x SJL)F1 mice, (iii) prevents EAE when administered before or at the time of immunization with Ac1-11, and (iv) prevents EAE when administered later, near the time of disease onset. Initial studies suggest that Ac1-11[4A] does not prevent EAE by competitive inhibition or by activation of regulatory cells. Thus, substitution of a single amino acid in a myelin basic protein peptide confers the capacity to prevent rather than induce EAE, even after peptide-specific encephalitogenic T cells have been activated.